VistaGen Therapeutics Inc
NASDAQ:VTGN
Balance Sheet
Balance Sheet Decomposition
VistaGen Therapeutics Inc
VistaGen Therapeutics Inc
Balance Sheet
VistaGen Therapeutics Inc
| Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
3
|
10
|
13
|
1
|
103
|
68
|
17
|
119
|
67
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
3
|
10
|
13
|
1
|
103
|
68
|
17
|
119
|
67
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
3
|
1
|
2
|
2
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
3
|
11
|
14
|
2
|
104
|
71
|
18
|
121
|
82
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
3
|
3
|
2
|
2
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
3
|
3
|
2
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+200%
|
0
-67%
|
0
N/A
|
1
+233%
|
4
+270%
|
11
+205%
|
14
+24%
|
6
-59%
|
108
+1 767%
|
75
-31%
|
21
-72%
|
124
+486%
|
84
-32%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
1
|
3
|
3
|
2
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
2
|
1
|
2
|
2
|
1
|
3
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
3
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
3
|
2
|
5
|
17
|
2
|
1
|
2
|
3
|
3
|
4
|
6
|
5
|
5
|
13
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
3
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
6
|
3
|
3
|
2
|
2
|
3
|
4
|
9
|
12
|
4
|
4
|
4
|
1
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
6
N/A
|
13
+123%
|
13
-2%
|
21
+59%
|
4
-81%
|
3
-23%
|
4
+42%
|
7
+57%
|
12
+67%
|
16
+42%
|
10
-39%
|
9
-9%
|
9
+4%
|
14
+49%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
0
|
55
|
68
|
71
|
85
|
132
|
142
|
157
|
181
|
202
|
220
|
268
|
327
|
356
|
408
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
53
|
59
|
62
|
68
|
133
|
147
|
167
|
192
|
200
|
316
|
336
|
343
|
474
|
482
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
6
N/A
|
13
-121%
|
13
-2%
|
21
-60%
|
3
+85%
|
1
N/A
|
7
+1 050%
|
7
+3%
|
6
N/A
|
92
N/A
|
65
-30%
|
12
-81%
|
114
+845%
|
70
-38%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+200%
|
0
-67%
|
0
N/A
|
1
+233%
|
4
+270%
|
11
+205%
|
14
+24%
|
6
-59%
|
108
+1 767%
|
75
-31%
|
21
-72%
|
124
+486%
|
84
-32%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
6
|
7
|
7
|
27
|
29
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
7
|
4
|
4
|
4
|
4
|
4
|
0
|
0
|
0
|
0
|
|